Your browser doesn't support javascript.
loading
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial.
Groop, Per-Henrik; Cooper, Mark E; Perkovic, Vlado; Hocher, Berthold; Kanasaki, Keizo; Haneda, Masakazu; Schernthaner, Guntram; Sharma, Kumar; Stanton, Robert C; Toto, Robert; Cescutti, Jessica; Gordat, Maud; Meinicke, Thomas; Koitka-Weber, Audrey; Thiemann, Sandra; von Eynatten, Maximilian.
Affiliation
  • Groop PH; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.
  • Cooper ME; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Perkovic V; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
  • Hocher B; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
  • Kanasaki K; The George Institute for Global Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
  • Haneda M; Institute of Nutritional Science, University of Potsdam, Potsdam, Germany.
  • Schernthaner G; Department of Histology and Embryology, Medical College, Jinan University, Guangzhou, China.
  • Sharma K; IFLb, Institut für Laboratoriumsmedizin Berlin GmbH, Berlin, Germany.
  • Stanton RC; Department of Diabetology and Endocrinology, Kanazawa Medical University, Kanazawa, Japan.
  • Toto R; Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Kanazawa, Japan.
  • Cescutti J; Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Gordat M; Department of Internal Medicine, Rudolfstiftung Hospital, Vienna, Austria.
  • Meinicke T; Department of Medicine, Center for Renal Translational Medicine, University of California, San Diego, California.
  • Koitka-Weber A; Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
  • Thiemann S; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • von Eynatten M; Boehringer Ingelheim France S.A.S, Reims, France.
Diabetes Obes Metab ; 19(11): 1610-1619, 2017 11.
Article in En | MEDLINE | ID: mdl-28636754
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Albuminuria / Renal Insufficiency / Linagliptin / Hyperglycemia Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2017 Type: Article Affiliation country: Finland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Albuminuria / Renal Insufficiency / Linagliptin / Hyperglycemia Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2017 Type: Article Affiliation country: Finland